2010
DOI: 10.4158/ep09265.cr
|View full text |Cite
|
Sign up to set email alerts
|

Successful Treatment of Thyroid Storm with Plasmapheresis in a Patient with Methimazole-Induced Agranulocytosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
24
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
4
2
2

Relationship

0
8

Authors

Journals

citations
Cited by 54 publications
(25 citation statements)
references
References 13 publications
0
24
0
Order By: Relevance
“…In a recent case of TS, plasmapheresis was done post surgery, where sleeve pneumonectomy was the precipitating event and the patient had not responded to standard antithyroid treatment (19). In another case, plasmapheresis was opted for in a patient with Graves' disease having methimazole-induced agranulocytosis worsening to pericarditis, thrombocytopenia, and, finally, TS (17). While plasmapheresis was decidedly a therapeutic option, the challenge lay in the fact that plasmapheresis could potentially lead to hypocalcemia, which, in turn, could cause seizures.…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…In a recent case of TS, plasmapheresis was done post surgery, where sleeve pneumonectomy was the precipitating event and the patient had not responded to standard antithyroid treatment (19). In another case, plasmapheresis was opted for in a patient with Graves' disease having methimazole-induced agranulocytosis worsening to pericarditis, thrombocytopenia, and, finally, TS (17). While plasmapheresis was decidedly a therapeutic option, the challenge lay in the fact that plasmapheresis could potentially lead to hypocalcemia, which, in turn, could cause seizures.…”
Section: Discussionmentioning
confidence: 97%
“…It has been used in preoperative and post-operative management of severely hyperthyroid patients with contraindications to antithyroid drugs (13). It has also been used for the management of TS, predominantly in patients with Graves' disease with ophthalmopathy (14,15) or agranulocytosis (16,17) and in selected patients with toxic multinodular goiter (18). In a recent case of TS, plasmapheresis was done post surgery, where sleeve pneumonectomy was the precipitating event and the patient had not responded to standard antithyroid treatment (19).…”
Section: Discussionmentioning
confidence: 98%
“…Review of the literature of reported cases of agranulocytosis between 1999 and 2013 identified 80 cases where the presenting symptoms were described [13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37]. Fever (93.8%), sore throat (68.7%) and chills (21.2%) were the commonest presenting symptoms.…”
Section: Resultsmentioning
confidence: 99%
“…In addition, removal of circulating TSH receptor stimulating antibodies could be another possible mechanism leading to improvement in thyrotoxicosis (41). It was noted that the clinical improvement of thyrotoxicosis is more significant than the improvement of thyroid hormone levels after PP/TPE (37,39). The effect of PP/TPE on thyrotoxicosis is transient, lasting approximately 24-48 hours.…”
Section: Alternative Therapeutic Interventionsmentioning
confidence: 96%
“…Both procedures can effectively reduce circulating thyroid hormone levels within 3 days (37)(38)(39). Thyroid hormones are bound to plasma proteins.…”
Section: Alternative Therapeutic Interventionsmentioning
confidence: 98%